Table 2.
Basic and clinical characteristics of patients in the two groups
| Characteristics | Normal group | AML group | p-value |
|---|---|---|---|
| Gender | |||
| Male | 13 (65%) | 4 (7.26%) | 0.023 |
| Female | 7 (35%) | 11 (3.73%) | |
| Age, year | 33.27 ± 90.28 | 33.24 ± 00.37 | ≥ 0.001 |
| Less than 5 years (toddler) | 4 (20%) | 2 (3.13%) | |
| 5–13 years (child) | 6 (30%) | 2 (3.13%) | |
| 14–19 years (adolescent) | 1 (5%) | 0 (0%) | ≥ 0.001 |
| 20–55 years (adult) | 3 (15%) | 7 (7.46%) | |
| Over 55 years (older adult) | 6 (30%) | 4 (7.26%) | |
| Subtype | |||
| Common B | 0 (0%) | 0 (0%) | |
| M0 | 0 (0%) | 1 (7.6%) | |
| M1 | 0 (0%) | 4 (7.26%) | |
| M1/M2 | 0 (0%) | 1 (7.6%) | |
| M2 | 0 (0%) | 1 (7.6%) | |
| M4/M2 | 0 (0%) | 1 (7.6%) | ≥ 0.001 |
| M5 | 0 (0%) | 2 (3.13%) | |
| Non-M3 | 0 (0%) | 5 (3.33%) | |
| Pro B | 0 (0%) | 0 (0%) | |
| Relapsed B | 0 (0%) | 0 (0%) | |
| Relapsed T | 0 (0%) | 0 (0%) | |
| T | 0 (0%) | 0 (0%) | |
| Blast percentage | 53.0 ± 87.0 | 99.28 ± 13.5 | ≥ 0.001 |